Researchers conducted study to determine whether a microbiota-based investigational live biotherapeutic (RBX2660) decreases the risk for recurrent Clostridioides difficile infection.
Researchers conducted a study to determine whether the investigational oral microbiome therapeutic SER-109 decreases the risk for recurrent Clostridioides difficile infection.
Researchers studied alterations in the gut microbiome of patients with ankylosing spondylitis receiving treatment with adalimumab, as well the microbiome biomarkers that predict treatment response.
Researchers sought to determine whether alternative stable states exist in the intestinal ecosystem and if they could affect remission from ulcerative colitis.
Researchers sought to characterize how specific diets are associated with the gut microbiome and how these associations manifest in the gut microbial composition.
The investigators sought to determine the down-staging success rate and intention-to-treat outcomes according to uniform criteria in patients with hepatocellular carcinoma.
Researchers described the evolution of dietary patterns and the outcomes they have on the gut microbiome, immune function, and inflammation in people with IBD.
Researchers assessed the stability of the virome over time, the effect of diet and genetics, the impact of the virome on host gene expression, and whether specific viruses are associated with IBS subtypes.
Investigators conducted a study to determine the relationship between gut microbiota and ghrelin concentrations among patients with positive Helicobacter pylori infection vs those with antigen-negative H pylori infection who received eradication therapy.
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Researchers of a metagenomic analysis assessed the taxonomic and functional signatures of the gut microbiome in gout and its association with clinical parameters and response to therapeutic interventions.
The researchers tested whether daily fiber supplementation in addition to fecal microbial transplantation would improve cardiometabolic outcomes among severely obese patients.
Investigators sought to compare the gut microbiota composition of children with and without D fragilis colonization and assess the impact of metronidazole on gut microbiota diversity and composition in D fragilis carriers.
Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.
A team of researchers sought to determine role of the gut-brain axis as a possible therapeutic target for Theiler murine encephalomyelitis (TMEV) linked seizures.
